Cargando…
Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment
Pancreatic cancer is highly aggressive and lethal. Due to the lack of effective methods for detecting the disease at an early stage, pancreatic cancer is frequently diagnosed late. Gemcitabine has been the standard chemotherapy drug for patients with pancreatic cancer for over 20 years, but its anti...
Autor principal: | Nishimoto, Arata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372808/ https://www.ncbi.nlm.nih.gov/pubmed/36161054 http://dx.doi.org/10.3748/wjg.v28.i28.3637 |
Ejemplares similares
-
Combined targeted therapy and immunotherapy for cancer treatment
por: Guo, Cheng-Xiang, et al.
Publicado: (2021) -
Shattering the castle walls: Anti-stromal therapy for pancreatic cancer
por: Kanat, Ozkan, et al.
Publicado: (2018) -
Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy
por: Galanopoulos, Michail, et al.
Publicado: (2021) -
Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer
por: Davis, Harold W, et al.
Publicado: (2021) -
Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations
por: Guo, Songchuan, et al.
Publicado: (2017)